INSM financial statements
The full income statement, balance sheet, and cash-flow statement for Insmed Incorporated (INSM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 606M YoY+66.7% | 364M YoY+19.2% | 305M YoY+24.4% | 245M YoY+30.2% | 188M YoY+14.6% | |
| Cost of revenue | 123M YoY+43.4% | 85.7M YoY+30.8% | 65.6M YoY+19.0% | 55.1M YoY+24.9% | 44.2M YoY+10.7% | |
| Research & development | 771M YoY+28.9% | 598M YoY+4.8% | 571M YoY+43.6% | 398M YoY+45.7% | 273M YoY+50.6% | |
| Selling, general & administrative | 701M YoY+52.1% | 461M YoY+33.9% | 345M YoY+29.6% | 266M YoY+13.5% | 234M YoY+15.1% | |
| General & administrative | — | — | 345M YoY+29.6% | 266M YoY+13.5% | 234M YoY+15.1% | |
| Amortization of intangibles | 6.00M YoY+18.8% | 5.05M YoY+0.0% | 5.05M YoY-0.0% | 5.05M YoY+0.0% | 5.05M YoY+1.0% | |
| Operating income | -1.25B YoY-42.0% | -878M YoY-23.8% | -710M YoY-55.2% | -457M YoY-21.9% | -375M YoY-41.4% | |
| Interest expense | 83.8M YoY-1.3% | 84.9M YoY+3.9% | 81.7M YoY+208.9% | 26.4M YoY-34.7% | 40.5M YoY+36.9% | |
| Other non-operating income | -1.84M YoY-6448.3% | 29.0K YoY-98.4% | 1.86M YoY+131.3% | -5.94M YoY-78.3% | -3.33M YoY-922.2% | |
| Pre-tax income | -1.27B YoY-39.7% | -910M YoY-21.8% | -747M YoY-55.6% | -480M YoY-10.0% | -436M YoY-49.1% | |
| Income tax | 5.03M YoY+35.6% | 3.71M YoY+45.1% | 2.56M YoY+84.7% | 1.38M YoY+178.7% | -1.76M YoY-225.4% | |
-1.28B YoY-39.7% | -914M YoY-21.9% | -750M YoY-55.7% | -482M YoY-10.8% | -435M YoY-47.8% | ||
-$6.42 YoY-15.3% | -$5.57 YoY-4.3% | -$5.34 YoY-36.6% | -$3.91 YoY-0.8% | -$3.88 YoY-28.9% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.79B YoY+10.6% | 1.62B YoY+74.5% | 929M YoY-27.0% | 1.27B YoY+52.1% | 837M YoY+34.4% | ||
2.26B YoY+11.8% | 2.03B YoY+52.3% | 1.33B YoY-19.7% | 1.66B YoY+33.2% | 1.24B YoY+56.2% | ||
469M YoY+57.6% | 298M YoY+31.9% | 226M YoY+18.6% | 190M YoY+40.7% | 135M YoY+13.8% | ||
1.53B YoY-12.3% | 1.74B YoY+4.7% | 1.66B YoY+5.9% | 1.57B YoY+88.3% | 833M YoY+60.1% | ||
739M YoY+158.9% | 285M YoY+186.0% | -332M YoY-477.4% | 88.0M YoY-78.6% | 410M YoY+48.8% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
-935M YoY-36.7% | -684M YoY-27.5% | -536M YoY-33.9% | -400M YoY-10.2% | -363M YoY-65.6% | ||
-64.6M YoY+88.9% | -583M YoY-160.8% | -224M YoY-546.6% | -34.6M YoY+46.2% | -64.3M YoY-842.3% | ||
954M YoY-28.9% | 1.34B YoY+696.1% | 168M YoY-78.8% | 793M YoY+29.5% | 613M YoY+126.0% | ||
| FX effect on cash | 931K YoY+171.2% | -1.31M YoY-422.8% | -250K YoY+74.9% | -996K YoY-6.8% | -933K YoY-288.9% | |
| Net change in cash | -44.6M YoY-161.4% | 72.7M YoY+112.3% | -592M YoY-265.6% | 357M YoY+94.1% | 184M YoY+306.0% | |
| Interest paid | 55.4M YoY+36.4% | 40.6M YoY+13.4% | 35.8M YoY+252.3% | 10.2M YoY-6.7% | 10.9M YoY+18.5% | |
| Income taxes paid | 4.14M YoY+65.7% | 2.50M YoY+27.8% | 1.96M YoY+13.9% | 1.72M YoY+10.2% | 1.56M YoY+91.4% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 37.5B YoY+200.2% | 12.5B YoY+181.9% | 4.43B YoY+63.8% | 2.71B YoY-16.4% | 3.24B YoY-5.6% | |
| P/S | 61.9× YoY+80.1% | 34.4× YoY+117.6% | 15.8× YoY+41.3% | 11.2× YoY-35.0% | 17.2× YoY-17.6% | |
| P/B | 50.8× YoY+15.9% | 43.8× | — | — | 7.9× YoY-36.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: INSM's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all INSM filings on SEC EDGAR → Not investment advice.
